Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Claridgeon Oct 29, 2019 11:00pm
160 Views
Post# 30284700

RE:RE:RE:RE:RE:RE:Friday presentation info from Twitter

RE:RE:RE:RE:RE:RE:Friday presentation info from TwitterWinr88 / Hempdoc ... Excellent posts.  Couldn't agree more.

More data will get us the worldwide coverage we all want and all been waiting for, for so long.

More statistically significant data will remove any doubts, capture more seriously the attention of those that matter, rally more rapidly our main audience (urologists - i.e. those behind what will drive the real demand (and who will de facto attract interest of big pharmas), will allow to clarify where we stand among competition, etc ...., which will translate into proper and adequate market valuation.

You only have one chance to make a lasting impression.  TLT/UHN know when will be that right moment.

_________________

Hempdoc - (10/29/2019 8:14:47 PM)
RE:RE:RE:RE:RE:Friday presentation info from Twitter
winr88 wrote:
Hi Thor6570

 In my opinion.

Even if TLT invited the media I don't believe there is a story worth printing quite yet. To get full attention for the sake of Theralase, the media covering the story, investment groups coverage and the general public there must be a bit more "proof in the pudding" so to say. Perhaps after the FDA has approved the application for fasttrack and a few more sites for clinical studies with new Patient treatments announced then there is more certainty in exciting the public with a news release. Yes there are some undenialble results so far but releasing a story prior to more information coverage and clinical coverage may work against Theralase. 


Agree...I am sure our scientific team would frown upon any media coverage at such an early stage, & likely advised against any media coverage by TLT.

Bullboard Posts